Historical record - last NADAC effective date: 1/18/2023
Product Information
QUINAPRIL 20 MG TABLET is a generic product labeled by Aurobindo Pharma Limited, priced at $0.0964 per EA under NDC 65862061990. Its NADAC has been published 529 times since Nov 28, 2013.
FDA first approved this application on Apr 29, 2013. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
20 mg/1
Manufacturer
Aurobindo Pharma LimitedNDC
65862061990
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Effective Date
1/18/2023
Active Ingredients
QUINAPRIL HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA202725FDA Approved
4/29/2013
TE Code
AB
On Market Since
4/29/2013
Pharmacological Classes
Price Statistics
The NADAC for QUINAPRIL 20 MG TABLET has been published 529 times since Nov 28, 2013, and over the history we have for it it has declined 39.0%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0964 per EA |
|---|---|
| All-time high | $0.1634 (Mar 12, 2014) |
| All-time low | $0.0884 (Jul 20, 2022) |
| Median price | $0.1224 |
| Average price | $0.1246 |
| Largest weekly change | +17.5% (Feb 20, 2019) |
| Weeks tracked | 529 |
| Tracking since | Nov 28, 2013 |
1W
N/A
1M
N/A
3M
N/A
6M
N/A
1Y
N/A
3Y
0.0%
5Y
-18.5%
All
-39.0%
Last surveyed Jan 10, 2024 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the Quinapril Hydrochloride market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Aurobindo Pharma Limited manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Quinapril Hydrochloride market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Angiotensin Converting Enzyme Inhibitor class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of QUINAPRIL 20 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for QUINAPRIL 20 MG TABLET, manufactured by Aurobindo Pharma Limited, is $0.0964 per EA (NDC 65862061990), effective Jan 10, 2024.
How has the price of QUINAPRIL 20 MG TABLET changed over time?
Over the history we have for it, the NADAC for QUINAPRIL 20 MG TABLET has declined 39.0%. It has been tracked across 529 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for QUINAPRIL 20 MG TABLET?
Since Nov 28, 2013, the NADAC for QUINAPRIL 20 MG TABLET has ranged from a low of $0.0884 (Jul 20, 2022) to a high of $0.1634 (Mar 12, 2014), with a median of $0.1224 per EA.
Are there cheaper alternatives to QUINAPRIL 20 MG TABLET?
No other NADAC-published product currently shares the active ingredient and strength of QUINAPRIL 20 MG TABLET in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures QUINAPRIL 20 MG TABLET?
QUINAPRIL 20 MG TABLET (NDC 65862061990) is labeled by Aurobindo Pharma Limited, and CMS classifies it as a generic product.